A Phase I, Open-Label, Single-Dose Trial To Determine The Safety And Pharmacokinetics Of Minocin (Minocycline) For Injection In Subjects With Renal Insufficiency
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Minocycline (Primary)
- Indications Renal failure
- Focus Adverse reactions
- Sponsors Rempex Pharmaceuticals
- 12 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017.
- 12 Jul 2017 Planned primary completion date changed from 1 May 2017 to 1 Dec 2017.
- 27 Apr 2017 Status changed from not yet recruiting to recruiting.